Arcadia Biosciences, Inc. (RKDA) Financials
RKDA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 23.5 million | 8.1 million |
2023-06-30 | 26.8 million | 9.1 million |
2023-03-31 | 30.4 million | 13.7 million |
2022-12-31 | 28.9 million | 8.0 million |
RKDA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.9 million | 162000 |
2023-06-30 | -4.8 million | 199000 |
2023-03-31 | -3.5 million | 212000 |
2022-12-31 | -2.4 million | 209000 |
RKDA Net Income
No data available :(
RKDA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 15.7 million | - | 1.3 million |
2023-06-30 | 18.5 million | - | 1.5 million |
2023-03-31 | 23.0 million | - | 1.8 million |
2022-12-31 | 20.6 million | - | 2.0 million |
RKDA Shares Outstanding
RKDA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 305000 | 3.4 million | - |
2023-06-30 | 5000 | 391000 | 3.8 million | - |
2023-03-31 | 5000 | 359000 | 4.4 million | - |
2022-12-31 | 26000 | 500000 | 4.2 million | - |
RKDA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.6 million | 1.1 million |
2023-06-30 | 1.4 million | 981000 |
2023-03-31 | 1.5 million | 825000 |
2022-12-31 | 1.0 million | 1.6 million |
RKDA
Price: $2.09
52 week price:
Earnings Per Share: -21.41 USD
P/E Ratio: -0.12
Exchange: NCM
Sector: Consumer Defensive
Industry: Packaged Foods
Volume: 191500
Ebitda: -4.4 millionMarket Capitalization: 2.3 million